![Raquel Izumi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raquel Izumi
Directeur Général chez
VINCERX PHARMA, INC.
Fortune : 1 008 $ au 31/07/2026
Profil
Raquel E.
Izumi is the founder.
Dr. Izumi was the founder of Acerta Pharma BV, serving as Executive VP-Clinical Development from 2013 to 2020.
Dr. Izumi was the founder of Aspire Therapeutics LLC, serving as Chief Scientific Officer from 2011 to 2013.
Dr. Izumi is the founder of Vincerx Pharma, Inc., serving as President, CEO, Chief Operating Officer & Director.
Dr. Izumi's current job is Independent Director at LifeSci Acquisition III Corp.
Dr. Izumi's former job was Senior Director-Clinical Development at Pharmacyclics LLC from 2010 to 2011.
Dr. Izumi earned a doctorate from the University of California, Los Angeles in 2000 and an undergraduate degree from the University of California, Santa Barbara in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VINCERX PHARMA INC 1,48% | 21/03/2025 | 77 555 ( 1,48% ) | 1 008 $ | 31/07/2026 |
Postes actifs de Raquel Izumi
| Sociétés | Poste | Début |
|---|---|---|
| VINCERX PHARMA, INC. | Directeur Général | - |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Anciens postes connus de Raquel Izumi
| Sociétés | Poste | Fin |
|---|---|---|
Vincera Pharma, Inc. /Old/
 Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage life sciences company which develops antibody drugs | Fondateur | 01/12/2020 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Fondateur | 01/05/2020 |
Aspire Therapeutics LLC | Fondateur | 01/02/2013 |
| PHARMACYCLICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2011 |
Formation de Raquel Izumi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Vincera Pharma, Inc. /Old/
Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage life sciences company which develops antibody drugs | Health Technology |
Vincerx Pharma, Inc.
 Vincerx Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer | Health Technology |
Aspire Therapeutics LLC | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
